Analysts See $0.03 EPS for Trevali Mining (TV); Caladrius Biosciences (CLBS) SI Increased By 71.43%

Trevali Mining Corporation (TSE:TV) Logo

Analysts expect Trevali Mining Corporation (TSE:TV) to report $0.03 EPS on May, 9.They anticipate $0.01 EPS change or 25.00% from last quarter’s $0.04 EPS. T_TV’s profit would be $24.53 million giving it 2.83 P/E if the $0.03 EPS is correct. After having $0.02 EPS previously, Trevali Mining Corporation’s analysts see 50.00% EPS growth. The stock decreased 2.86% or $0.01 during the last trading session, reaching $0.34. About 182,040 shares traded. Trevali Mining Corporation (TSE:TV) has 0.00% since May 1, 2018 and is . It has underperformed by 4.37% the S&P500. Some Historical TV News: 26/03/2018 - The Klein Law Firm Announces Commencement of a Class Action Filed on Behalf of Grupo Televisa S.A.B. Shareholders and a Lead; 13/03/2018 - MEXICO’S GRUPO TELEVISA SAYS AGREED TO SELL 50 PCT STAKE IN TELEVISA CJ GRAND; 27/04/2018 - TELEVISA TO FOCUS ON EXPANDING SKY OPS OUTSIDE MEXICO: ANGOITIA; 23/03/2018 - The Klein Law Firm Announces a Class Action Filed on Behalf of Grupo Televisa S.A.B. Shareholders and a Lead Plaintiff Deadline of May 4, 2018; 27/03/2018 - S&PGR Assigns ‘BBB+’ Debt Rating On Grupo Televisa; 27/04/2018 - TELEVISA HAS REDUCED HEADCOUNT IN FINANCE, ADMIN UNITS BY 10%; 26/03/2018 - The Klein Law Firm Announces Commencement of a Class Action Filed on Behalf of Grupo Televisa S.A.B. Shareholders and a Lead Plaintiff Deadline of May 4, 2018; 27/04/2018 - TELEVISA TO DECIDE ON CABLE UNIT SPIN OFF THIS YR: ANGOITIA; 26/04/2018 - TELEVISA 1Q OPER INCOME MXN3.62B; 05/03/2018 - Pomerantz Law Firm Announces the Filing of a Class Action against Grupo Televisa, S.A.B. and Certain Officers — TV

Caladrius Biosciences Inc (NASDAQ:CLBS) had an increase of 71.43% in short interest. CLBS’s SI was 27,600 shares in May as released by FINRA. Its up 71.43% from 16,100 shares previously. With 40,600 avg volume, 1 days are for Caladrius Biosciences Inc (NASDAQ:CLBS)’s short sellers to cover CLBS’s short positions. The stock decreased 0.79% or $0.024 during the last trading session, reaching $3.006. About 4,178 shares traded. Caladrius Biosciences, Inc. (NASDAQ:CLBS) has declined 15.79% since May 1, 2018 and is downtrending. It has underperformed by 20.16% the S&P500. Some Historical CLBS News: 08/03/2018 - Caladrius Biosciences: Treatment Continues to Be Well-Tolerated and Deemed Non-Futile for Therapeutic Effect; 08/03/2018 - CALADRIUS BIOSCIENCES REPORTS INTERIM ANALYSIS FOR PHASE 2 T-REX TRIAL OF CLBS03 FOR TYPE 1 DIABETES; 06/03/2018 - CALADRIUS BIOSCIENCES INC - UNDER DEAL TERMS , ACQUIRED EXCLUSIVE WORLDWIDE RIGHTS TO DATA SET, REGULATORY FILINGS FOR CD34+ CELL THERAPY PROGRAM; 06/03/2018 - CALADRIUS BIOSCIENCES INC - IN EXCHANGE, SHIRE WILL RECEIVE UNDISCLOSED UP-FRONT CONSIDERATION, MILESTONES AND A ROYALTY ON PRODUCT SALES; 22/03/2018 - Caladrius Biosciences 4Q Loss/Shr 29c; 06/03/2018 Caladrius Biosciences Acquires an Exclusive License to a Late Stage CD34+ Cell Therapy Program for the Treatment of Refractory; 07/05/2018 - Caladrius Biosciences Access Event Set By Chardan for May. 14; 10/04/2018 - Caladrius Biosciences Receives SAKIGAKE Expedited Review Designation in Japan for CLBS12 for Treating Critical Limb lschemia; 19/04/2018 - DJ Caladrius Biosciences Inc, Inst Holders, 1Q 2018 (CLBS); 06/03/2018 - CALADRIUS BUYS EXCLUSIVE LICENSE TO CD34+ CELL THERAPY PROGRAM

More notable recent Caladrius Biosciences, Inc. (NASDAQ:CLBS) news were published by: Finance.Yahoo.com which released: “How Does Caladrius Biosciences, Inc. (NASDAQ:CLBS) Affect Your Portfolio Volatility? - Yahoo Finance” on April 25, 2019, also Globenewswire.com with their article: “New Research: Key Drivers of Growth for Sunworks, Murphy, WNS (Holdings), Caladrius Biosciences, Full House Resorts, and Kewaunee Scientific — Factors of Influence, Major Initiatives and Sustained Production - GlobeNewswire” published on April 17, 2019, Seekingalpha.com published: “BTE, BRSS, WVE and FLXN among notable midday movers - Seeking Alpha” on April 10, 2019. More interesting news about Caladrius Biosciences, Inc. (NASDAQ:CLBS) were released by: Benzinga.com and their article: “Daily Biotech Pulse: NASH Cheer For Intercept, Gilead Layoffs, BioDelivery Licenses Constipation Drug - Benzinga” published on April 11, 2019 as well as Globenewswire.com‘s news article titled: “Caladrius Biosciences to Participate in Upcoming Conferences - GlobeNewswire” with publication date: April 03, 2019.

Among 2 analysts covering Caladrius Biosciences (NASDAQ:CLBS), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Caladrius Biosciences had 3 analyst reports since February 27, 2019 according to SRatingsIntel. H.C. Wainwright maintained the stock with “Buy” rating in Friday, March 15 report. On Friday, March 15 the stock rating was maintained by Chardan Capital Markets with “Buy”.

More notable recent Trevali Mining Corporation (TSE:TV) news were published by: Seekingalpha.com which released: “Entravision’s Mispriced Assets Have Significant Potential - Entravision Communications Corporation (NYSE:EVC) - Seeking Alpha” on May 01, 2019, also Seekingalpha.com with their article: “AT&T: The Market Is Wrong - Seeking Alpha” published on April 25, 2019, Benzinga.com published: “Wall Street Reacts To WWE’s (NYSE:WWE) Earnings Miss: Bruised And Battered, But Not Broken - Benzinga” on April 26, 2019. More interesting news about Trevali Mining Corporation (TSE:TV) were released by: Benzinga.com and their article: “JPMorgan Raises WWE’s Price Target, Bullish On ‘Smackdown’ Future (NYSE:WWE)(NASDAQ:FOXA) - Benzinga” published on April 23, 2019 as well as Fool.com‘s news article titled: “T-Mobile’s “Disruptive” Cable TV Offering Makes Its Debut - The Motley Fool” with publication date: April 10, 2019.

Trevali Mining Corporation, a natural resource company, engages in the acquisition, exploration, development, and production of mineral properties in Peru and Canada. The company has market cap of $277.98 million. It explores for zinc, lead, silver, copper, and gold deposits. It currently has negative earnings. The firm primarily holds interests in the Santander property covering an area of 4,455 hectares located on the western edge of the Altiplano, Peru; and the Caribou property covering an area of 3,105.7 hectares located in the province of New Brunswick, Canada.

Among 5 analysts covering Trevali Mining (TSE:TV), 3 have Buy rating, 0 Sell and 2 Hold. Therefore 60% are positive. Trevali Mining had 5 analyst reports since February 20, 2019 according to SRatingsIntel. Scotia Capital maintained the shares of TV in report on Thursday, February 21 with “Hold” rating. The stock of Trevali Mining Corporation (TSE:TV) earned “Buy” rating by National Bank Canada on Monday, February 25. The firm has “Buy” rating by Canaccord Genuity given on Thursday, February 21. The rating was downgraded by IBC on Tuesday, February 26 to “Hold”. As per Wednesday, February 20, the company rating was maintained by BMO Capital Markets.

Caladrius Biosciences, Inc. (NASDAQ:CLBS) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.